-
Kissei Pharmaceutical is a
pharmaceutical company based in Matsumoto, Nagano, ****an.
Products discovered or
developed by
Kissei include: Difelikefalin...
- the
brand name Urief,
which is
jointly marketed by
Kissei Pharmaceutical and
Daiichi Sankyo.
Kissei licensed the US, Canadian, and
Mexican rights for silodosin...
- (INN,
brand name Rizaben) is an
antiallergic drug. It was
developed by
Kissei Pharmaceuticals and was
approved in 1982 for use in ****an and
South Korea...
- gonadotropin-releasing
hormone antagonist (GnRH antagonist)
developed by
Kissei Pharmaceutical and ObsEva. In June 2022, it was
approved for
medical use...
- Inc. and was
later developed in ****an by
Kyorin Pharmaceutical Co., Ltd,
Kissei Pharmaceutical Co., Ltd, and
Urovant Sciences. It was
approved for medical...
- (1974– )
Kimia Farma (1971– )
Kinetic Concepts (pharma activities: 2008– )
Kissei (1946– ) Kite (2009– )
Knight (1995– )
Kunming (Before 2007– )
Kyowa Kirin...
- of
blood glucose-lowering
drugs and is
currently co-marketed in ****an by
Kissei and Takeda. The
North America rights to
mitiglinide are held by
Elixir Pharmaceuticals...
-
Ichikawa (2019–2020) Boys Run the Riot (ボーイズ・ラン・ザ・ライオット) by
Keito Gaku (2020)
Kissei Rettō (寄生列島) by
Edogawa Edogawa (2020–2021)
Bukuro Kicks (ブクロキックス) by Matsuki...
-
Archived from the
original on 2019-04-22.
Retrieved 2018-11-12. "Linzagolix -
Kissei Pharmaceutical/ObsEva - AdisInsight". Ezzati, Mohammad; Carr,
Bruce R (2015)...
-
Hyperparathyroidism in
Dialysis Patients" (Press release).
Sanwa Kagaku Kenkyusho Co. and
Kissei Pharmaceutical Co. June 23, 2021.
Retrieved December 11, 2021.
Akizawa T...
